Literature DB >> 9614014

Community acquired pneumonia in elderly people. Current British guidelines need revision.

S J Wort, T R Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9614014      PMCID： PMC1113272          DOI： 10.1136/bmj.316.7146.1690

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.

Authors:  K P Klugman
Journal:  J Antimicrob Chemother       Date:  1996-07       Impact factor: 5.790

2.  Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

Authors:  A P Johnson; D C Speller; R C George; M Warner; G Domingue; A Efstratiou
Journal:  BMJ       Date:  1996-06-08

Review 3.  Chlamydia pneumoniae.

Authors:  P J Cook; D Honeybourne
Journal:  J Antimicrob Chemother       Date:  1994-12       Impact factor: 5.790

Review 4.  Pneumonia in the elderly.

Authors:  M Woodhead
Journal:  J Antimicrob Chemother       Date:  1994-08       Impact factor: 5.790

5.  Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group.

Authors:  A Ortqvist; M Valtonen; O Cars; M Wahl; P Saikku; C Jean
Journal:  Chest       Date:  1996-12       Impact factor: 9.410

6.  Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

Authors:  C McNulty; M Logan; I P Donald; D Ennis; D Taylor; R N Baldwin; M Bannerjee; K A Cartwright
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790

7.  Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.

Authors:  P H Orr; R W Peeling; M Fast; J Brunka; H Duckworth; G K Harding; L E Nicolle
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

Review 8.  Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society.

Authors: 
Journal:  Br J Hosp Med       Date:  1993 Mar 3-16

Review 9.  Comparison of macrolide antibiotics.

Authors:  J D Williams; A M Sefton
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

10.  Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial.

Authors:  R Chan; L Hemeryck; M O'Regan; L Clancy; J Feely
Journal:  BMJ       Date:  1995-05-27
View more
  3 in total

1.  Community acquired pneumonia in elderly people. Addition of erythromycin is not currently justified.

Authors:  M Woodhead
Journal:  BMJ       Date:  1998-11-28

2.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

3.  Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples.

Authors:  C Y Tong; C Donnelly; G Harvey; M Sillis
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.